Aortic diseases
Conditions
Interventions
EVAR contrast dilution:half dilution of contrast in the power injector
EVAR standard contrast:original concentration of contrast in the power injector
TEAVR contrast dilution:half dilution of contrast in the power injector
TEVAR standard contrast:original concentration of contrast in the power injector
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Cohort EVAR: 1) patients schedule for EVAR due to infrarenal AAA or common iliac artery aneurysms (CIAA) and 2) patients who sign informed consent informs. Cohort TEVAR: 1) plan TEVAR due to TBAD or DTAA and 2) sign informed consent.
Exclusion criteria
Exclusion criteria: Cohort EVAR and TEVAR (Participants will be excluded if they meet one of the following criteria): 1) patients require emergent surgery for ruptured aortic diseases in hemodynamic unstable status, 2) patients are admitted for reintervention due to endoleak or stent-induced new entry tear, 3) patients refuse to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of patients who develop acute kidney injury (AKI);Freedom of major adverse kidney events (MAKE); | — |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of patients who develop MAKE;Freedom of all types of endoleaks; | — |
Countries
China
Contacts
Public ContactJichun Zhao
West China Hospital, Sichuan University
Outcome results
None listed